Biosite Diagnostics receives FDA clearance

BSTE received FDA clearance to market the Triage B-type natriuretic peptide (BNP) test for congestive heart failure (CHF). The test already is marketed in Europe. BSTE was up $7 (27 percent) to $33 on...